thymidylate synthase/dihydrofolate reductase inhibitors (Yale/Yale School of Medicine/Texas Medical Branch at Galveston/Duquesne University)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namethymidylate synthase/dihydrofolate reductase inhibitors (Yale/Yale School of Medicine/Texas Medical Branch at Galveston/Duquesne University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitorsThymidylate synthase inhibitors
TargetsThymidylate synthaseDihydrofolate reductase
Therapy Area/IndicationsCryptosporidiosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesYale University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesYale School Of MedicineYale UniversityDuquesne University +[4] 
Active IndicationsN/A
Inactive IndicationsCryptosporidiosis

Other Information

ATC CodeN/A
Related LinksN/A